Advait Badkar, Ph.D., Executive Director- Drug Product Design and Development & Head of Advanced Drug Delivery, Pharmaceutical Research and Development, Biotherapeutics Pharmaceutical Sciences, Pfizer Inc.
As Executive Director of Drug Product Design & Development at Pfizer, Advait Badkar leads a global organization within Biotherapeutics Pharmaceutical Sciences that drives innovation across the company’s biotech and vaccine portfolio. His leadership spans the full continuum of drug product development—from early research through licensure and commercial lifecycle management—ensuring robust formulation and process strategies for a wide range of modalities including peptides, both microbial and mammalian-derived proteins, vaccines, and RNA-based therapeutics. As Head of Advanced Drug Delivery, he provides scientific, technical, strategic, and regulatory leadership for Pfizer’s portfolio programs that depend on next-generation delivery technologies. Additional info:
Advait holds a Ph.D. in Pharmaceutical Sciences from Mercer University, an M.S. in Pharmaceutics from Auburn University, and a B.S. in Pharmacy from Pune University. He is an Adjunct Full Professor in the Department of Biomedical and Pharmaceutical Sciences at the University of Rhode Island, serves on the Board of Directors of the Subcutaneous Drug Delivery Consortium, and is an active member of the American Association of Pharmaceutical Scientists and the Controlled Release Society. Advait is an inventor on more than 12 patents, has authored over 35 peer-reviewed publications, and delivered more than 50 scientific presentations.
Stacia Furtado, PhD; Senior Manager, MSAT (Manufacturing Science and Technology)
Stacia leads the Manufacturing Science and Technology (MSAT) team across Organogenesis’s Rhode Island and Massachusetts locations, focusing on seamless technology transfer from development through commercial operations. She is dedicated to mentoring scientific staff and driving continuous improvement through strategic operational planning. By prioritizing professional development and organizational best practices, Stacia empowers her team to solve complex challenges while building scalable processes. Her leadership ensures that manufacturing transitions are efficient and focused on long-term success.
Kristen Dowling; Quality Assurance Senior Manager, Amgen
Senior Quality Assurance Manager responsible for oversight of multi-product Drug Substance and QC operations in a biologics manufacturing environment. Manages analytical investigations, CAPAs, change controls, laboratory compliance, and QC electronic systems to ensure GMP compliance and data integrity. Leads cross-functional teams supporting analytical method transfer and validation, inspection readiness, sampling plans, KPI reporting, and regulatory response activities while enabling risk-based quality decisions and continuous improvement initiatives.
Daniel Magiera, Founder and CEO Molecular MS Diagnostics, LLC
Daniel is the Founder and CEO of Molecular MS Diagnostics (MMSD), LLC for 18 years. He is passionate about building strong client relationships and helping pharmaceutical, biotechnology, and life sciences companies move their products forward with confidence. At MMSD, his focus is leading a team committed to delivering high-quality analytical, bioanalytical, and strategic product development services while making sure every client feels supported, valued, and set up for success.